Concretely: HJ · liraglutide.
I would like to know the limits of what can be inferred from this.
What I am trying to avoid is over-reading a single result, which I have done before.
What can I legitimately conclude from this figure?
Concretely: HJ · liraglutide.
I would like to know the limits of what can be inferred from this.
What I am trying to avoid is over-reading a single result, which I have done before.
What can I legitimately conclude from this figure?
The relevant detail is that a net-peptide-content figure already accounts for it, which is why net content is the number worth asking for.
Acetate salts are produced by a deliberate ion exchange after purification. The exchange costs a processing step and is the reason acetate-form material is more expensive.
Trifluoroacetate has documented biological effects at higher concentrations in cell culture, which is the technical reason acetate exchange exists rather than a marketing one.
Counter-ion content scales with the number of basic residues, following directly from charge balance.
Nothing here is medical advice, and research-use compounds are not approved for human use.
Trifluoroacetate unless a deliberate exchange was done. Ask which.
edited 7 Nov 2024 by tare_weight — added the placebo-arm figures
Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.
Browse resultsThis is the other half of the reconciliation problem, alongside water content.
Worked reconciliation: a 10 mg vial at four per cent water and eight per cent trifluoroacetate contains 10.0 × 0.88 = 8.8 mg of peptide, a twelve per cent shortfall against label with a perfectly clean purity figure.
Peptides purified by reverse-phase chromatography with a trifluoroacetic acid mobile phase are isolated as trifluoroacetate salts. The trifluoroacetate content depends on the number of basic residues and can run from a few per cent to well over ten by mass on a heavily basic sequence.
Peptides from reverse-phase purification with trifluoroacetic acid mobile phases are isolated as trifluoroacetate salts, which is standard synthesis practice.
Absence of a counter-ion figure is an absent measurement rather than a low one.
Water plus counter-ion is why gross mass and peptide mass differ.
Answer first: the counter-ion is part of the mass you paid for and none of the peptide you wanted, and it can run to several per cent or more.
Quantification differs by ion: trifluoroacetate by ion chromatography or by fluorine nuclear magnetic resonance, acetate by ion chromatography or by capillary electrophoresis. Neither shows up on a UV chromatogram.
Concretely, a supplier who reports both water and counter-ion has given you everything needed to reconcile the vial, and on this site that is a very short list.
Purity says nothing about counter-ion. They are unrelated measurements.
The short version: peptides are supplied as salts, the salt is real mass, and neither purity nor a chromatogram will tell you how much of it there is.
The number of basic residues drives counter-ion load, because each protonated basic site pairs with one counter-ion. A sequence with several lysines and arginines carries proportionally more.
Net peptide content varies between lots as the process varies, so one figure does not characterise a supplier.
Count the basic residues and you can estimate the counter-ion load.
Answering this needs the purification method, since a trifluoroacetic acid mobile phase leaves trifluoroacetate unless a deliberate exchange was performed.
Net peptide content — the fraction of gross mass that is the peptide itself — is the figure that folds water and counter-ion together and is what you should ask for if you ask for anything.
Trifluoroacetate effects in cell culture are documented and are the technical basis for salt exchange to acetate.
The caveat is that a purity figure is completely blind to counter-ion content, and the two are routinely conflated.
Ask for net peptide content. It folds water and counter-ion into one usable number.
edited 6 Dec 2024 by hana_petrikova — added the method parameters
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.